Serge Belanger
Stock Analyst at Needham
(4.11)
# 378
Out of 4,827 analysts
343
Total ratings
50.78%
Success rate
10.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $42 → $40 | $19.27 | +107.58% | 8 | May 8, 2025 | |
| EOLS Evolus | Reiterates: Buy | $22 | $10.09 | +118.04% | 15 | May 8, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $38 → $36 | $12.78 | +181.69% | 16 | May 7, 2025 | |
| CRMD CorMedix | Maintains: Buy | $12 → $15 | $12.03 | +24.69% | 17 | May 7, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $5 → $4 | $0.89 | +348.03% | 20 | May 7, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $14 | $7.45 | +87.92% | 3 | May 6, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $15 → $17 | $9.92 | +71.37% | 13 | May 6, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $32.48 | +121.67% | 22 | May 2, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $66 | $39.76 | +66.00% | 12 | Apr 30, 2025 | |
| HRTX Heron Therapeutics | Reiterates: Buy | $4 | $2.17 | +84.33% | 22 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $15.35 | +62.87% | 28 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $24.65 | - | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $27.27 | +68.68% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $13.52 | +47.98% | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.42 | - | 18 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.85 | +371.09% | 14 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $24.91 | +28.46% | 27 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $6.60 | +263.64% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.19 | +129.70% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.31 | - | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $35.54 | +68.82% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.62 | - | 1 | Mar 31, 2022 |
NewAmsterdam Pharma Company
May 8, 2025
Maintains: Buy
Price Target: $42 → $40
Current: $19.27
Upside: +107.58%
Evolus
May 8, 2025
Reiterates: Buy
Price Target: $22
Current: $10.09
Upside: +118.04%
Viridian Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $38 → $36
Current: $12.78
Upside: +181.69%
CorMedix
May 7, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $12.03
Upside: +24.69%
Esperion Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.89
Upside: +348.03%
Ocular Therapeutix
May 6, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $7.45
Upside: +87.92%
BioCryst Pharmaceuticals
May 6, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $9.92
Upside: +71.37%
Cytokinetics
May 2, 2025
Reiterates: Buy
Price Target: $72
Current: $32.48
Upside: +121.67%
MoonLake Immunotherapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $66
Current: $39.76
Upside: +66.00%
Heron Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $2.17
Upside: +84.33%
Apr 10, 2025
Reiterates: Buy
Price Target: $25
Current: $15.35
Upside: +62.87%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $24.65
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $27.27
Upside: +68.68%
Apr 9, 2025
Reiterates: Buy
Price Target: $20
Current: $13.52
Upside: +47.98%
Apr 9, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.42
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $0.85
Upside: +371.09%
Apr 8, 2025
Reiterates: Buy
Price Target: $32
Current: $24.91
Upside: +28.46%
Apr 8, 2025
Reiterates: Buy
Price Target: $24
Current: $6.60
Upside: +263.64%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $12.19
Upside: +129.70%
Apr 1, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.31
Upside: -
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $35.54
Upside: +68.82%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.62
Upside: -